Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
- Conditions
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2013-03-08
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 37
- Registration Number
- NCT00086931
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2013-02-01
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 10
- Registration Number
- NCT00087334
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant
- First Posted Date
- 2004-06-17
- Last Posted Date
- 2011-03-07
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 36
- Registration Number
- NCT00003894
- Locations
- ๐บ๐ธ
Louisiana State University School of Medicine, New Orleans, Louisiana, United States
๐บ๐ธBrooke Army Medical Center, Fort Sam Houston, Texas, United States
๐บ๐ธRoswell Park Cancer Institute, Buffalo, New York, United States
Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
- Conditions
- First Posted Date
- 2004-06-17
- Last Posted Date
- 2011-03-01
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 120
- Registration Number
- NCT00003898
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
๐บ๐ธSimmons Cancer Center - Dallas, Dallas, Texas, United States
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
- Conditions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2013-01-31
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 2
- Registration Number
- NCT00084721
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
- Conditions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2014-01-13
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 53
- Registration Number
- NCT00084708
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
- Conditions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 61
- Registration Number
- NCT00084734
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate
- Conditions
- Interventions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 25
- Registration Number
- NCT00084864
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder
- Conditions
- First Posted Date
- 2004-06-11
- Last Posted Date
- 2012-01-12
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT00084942
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
- Conditions
- First Posted Date
- 2004-05-21
- Last Posted Date
- 2013-02-01
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT00004122
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States